Eligible Registrants – AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 15 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 12 13 14 15 presentations: 1 to 25 of 374
Panel Discussion
Richard Pazdur
U.S. Food and Drug Administration, Silver Spring, MD, United States
Marc Theoret
U.S. Food and Drug Administration, Silver Spring, MD, United States
Israel Lowy
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States
Alan B. Sandler
Genentech, South San Francisco, CA, United States
Hesham A. Abdullah
AstraZeneca Pharmaceuticals LP, Rockville, MD, United States
Scot W. Ebbinghaus
Merck Research Laboratories - Rahway, North Wales, PA, United States
Kevin Chin
EMD Serono, Billerica, MA, United States
Fouad Namouni
Bristol-Myers Squibb Co., Lawrenceville, NJ, United States
from AACR Annual Meeting 2019 on April 1, 2019 3:00 PM-4:45 PM
Key questions for ctDNA analysis
Paul T Spellman
Oregon Health Science Univ., Portland, OR, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Title to be announced
Jamie Platt
Inivata, Research Triangle Park, NC, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
The dual roles of analytical and clinical data in ctDNA test validation
Justin Odegaard
Guardant Health Inc., Redwood City, CA, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Analytical validation of liquid biopsy assays: current challenges and opportunities
Mark Sausen
Personal Genome Diagnostics, Baltimore, MD, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Introduction
Richard M. Marais
Cancer Research UK Manchester Inst., Manchester, United Kingdom
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Invited Speaker
John S Haurum
Cambridge, United Kingdom
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Invited Speaker
Susan M. Galbraith
AstraZeneca, Cambridge, United Kingdom
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Invited Speaker
Joanne M. Hackett
Genomics England, London, United Kingdom
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Wrap-up
C. Simone Fishburn
BioCentury, Inc., Redwood City, CA, United States
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Panel Discussion
C. Simone Fishburn
BioCentury, Inc., Redwood City, CA, United States
Richard M. Marais
Cancer Research UK Manchester Inst., Manchester, United Kingdom
John S Haurum
Cambridge, United Kingdom
Susan M. Galbraith
AstraZeneca, Cambridge, United Kingdom
Joanne M. Hackett
Genomics England, London, United Kingdom
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Chairperson
George J Weiner
Univ. of Iowa Holden Comp. Cancer Ctr., Iowa City, IA, United States
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Invited Speaker
William Foster
Independent Advocate, Gary, IN, United States
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Invited Speaker
Andreana Natalie Holowatyj
Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Invited Speaker
Brittany A. Avin
Johns Hopkins Univ. School of Medicine, Baltimore, MD, United States
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Immune-based therapies: Predictors of benefit
Mario Sznol
Yale Cancer Ctr., New Haven, CT, United States
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Genomic profiling-identifying drivers
Funda Meric-Bernstam
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Companion and complementary diagnostics to inform drug development and approval
Gideon Blumenthal
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Practicing precision medicine: One patient at a time
Shivaani Kummar
Stanford University School of Medicine, Palo Alto, CA, United States
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Introduction
Joshua L. Berlin
Biocentury, Redwood City, CA, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
Invited Speaker
Dan Zhang
Foundation Medical Development Ltd., Beijing, China
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
Invited Speaker
Frank Jiang
CStone Pharmaceuticals, Shanghai, China
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
Invited Speaker
Joan Shen
I-Mab Biopharma, Shanghai, China
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
Panel Discussion
Joshua L. Berlin
BioCentury, Inc., Redwood City, CA, United States
Dan Zhang
Foundation Medical Development Ltd., Beijing, China
Frank Jiang
CStone Pharmaceuticals, Shanghai, China
Joan Shen
I-Mab Biopharma, Shanghai, China
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
CBER, Microbiome, and CAR-T in Solid Tumors
Ke Liu
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
<< first | < prev page: of 15 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 12 13 14 15 presentations: 1 to 25 of 374